Nayak Sanjay — SEC Form 4 filings
SEC reporting owner CIK 2012715. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-26.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-26 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 11 filings — 29,302 shares, $261,545 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 10,348 shares @ $9.04 ($93,546) in OCULAR THERAPEUTIX, INC, filed 2026-02-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | Chief Strategy Officer | 14 | — | 11 legs · 29,302 sh · $261,545 | 6 |
Form 4 filings — Nayak Sanjay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,897 @ $10.78 | EDGAR |
| 2026-05-28 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,858 @ $8.20 | EDGAR |
| 2026-02-25 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,759 @ $8.28 | EDGAR |
| 2026-02-17 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 10,348 @ $9.04 | EDGAR |
| 2026-01-06 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/award (A): 64,900 @ $0 · Grant/award (A): 197,650 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,878 @ $12.04 | EDGAR |
| 2025-08-27 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,885 @ $12.04 | EDGAR |
| 2025-05-27 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,862 @ $7.17 | EDGAR |
| 2025-02-26 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,895 @ $6.84 | EDGAR |
| 2025-02-13 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/award (A): 111,000 @ $0 · Grant/award (A): 334,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,814 @ $9 | EDGAR |
| 2024-08-27 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 1,832 @ $9.02 | EDGAR |
| 2024-05-28 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Sale (S): 2,274 @ $5.84 | EDGAR |
| 2024-02-26 | 4 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/award (A): 80,300 @ $0 · Grant/award (A): 244,550 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2012715 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →